Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

C3_LIP_ORAL_PHARYNX_NAS_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C14 Hospital discharge: ICD-9 — 149 Hospital discharge: ICD-8 — 149 Cause of death: ICD-10 — C14 Cause of death: ICD-9 — 149 Cause of death: ICD-8 — 149 Cancer registry: Topography ICD-O-3 — C14 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	85
4. Check minimum number of events None	85
5. Include endpoints None	85
6. Filter based on genotype QC (FinnGen only)	85

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_LIP_ORAL_PHARYNX_NAS_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C14
HD_ICD_9	149
HD_ICD_8	149
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C14
COD_ICD_9	149
COD_ICD_8	149
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C14
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	85	19	66
Unadjusted period prevalence (%)	0.02	0.01	0.03
Median age at first event (years)	67.29	65.01	67.95

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726)

17.29

26.69

1.6

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

8.39

13.92

2.9

1.3

0.2

g/l

0.68

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

235

4.80

11.34

5.4

3.8

—

(40768804) Tissue Pathology biopsy report

172

4.23

9.93

3.3

1.6

—

(3023368) Bacteria identified in Blood by Culture

147

4.05

9.12

4.2

4.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

18.86

8.87

1.3

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4.31

8.45

7.7

2.8

0.8

mmol/l

3.28

(3013650) Neutrophils [#/volume] in Blood by Automated count

299

3.56

7.28

13.9

6.2

4.3

4.2

e9/l

0.10

251

(3044640) Blood type and Crossmatch panel - Blood

164

3.38

6.91

3.7

2.2

—

(3032080) INR in Blood by Coagulation assay

239

3.32

6.89

6.4

8.9

1.4

inr

0.04

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

123

3.39

6.38

3.4

2.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.83

6.35

2.4

1.9

—

(3002256) Pathology report gross observation

4.35

5.68

1.6

1.1

—

(3042936) Bacteria identified in Isolate by Culture

3.38

5.30

2.0

1.8

—

(42870588) Differential panel, method unspecified - Blood

184

2.79

4.95

5.2

5.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

9.40

3.85

1.1

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4.40

3.82

10.4

7.3

—

(3001604) Monocytes [#/volume] in Blood

267

2.34

3.63

6.1

5.5

0.7

0.6

e9/l

0.74

225

(3006315) Basophils [#/volume] in Blood

267

2.34

3.63

7.0

5.5

0.0

e9/l

0.45

229

(3018010) Neutrophils/100 leukocytes in Blood

251

2.33

3.57

6.5

5.6

64.4

57.5

2.55

227

(3002030) Lymphocytes/100 leukocytes in Blood

252

2.32

3.53

5.5

5.8

22.8

27.2

1.48

224

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.91

3.30

1.2

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.66

3.00

1.7

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

8.75

2.78

1.0

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

4.66

2.53

2.7

4.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

100

2.31

2.46

2.0

2.3

2.5

2.4

mmol/l

0.95

(3003396) Base excess in Arterial blood by calculation

2.46

2.27

9.1

6.2

1.5

1.8

mmol/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

107

2.14

2.08

4.6

4.8

—

(3018418) pH of Serum or Plasma

154

1.99

2.08

5.5

3.6

7.4

—

(3000494) Fungus identified in Specimen by Culture

2.38

2.01

1.3

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

4.75

1.97

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

136

1.95

1.83

1.4

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.84

1.77

8.5

7.3

24.9

25.1

mmol/l

—

(3000850) Epithelial cells [#/volume] in Urine

122

1.96

1.75

2.0

9.3

5.1

e6/l

0.41

108

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.43

1.72

1.7

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3.72

1.64

2.2

1.7

—

(3026782) Osmolality of Urine

109

1.96

1.64

1.8

2.4

428.2

560.4

mosm/kgh2o

1.79

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

3.47

1.54

1.2

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.28

1.52

1.6

—

(40758558) Short blood count panel - Blood

120

1.87

1.51

10.8

5.0

—

(3022313) Gas panel - Capillary blood

2.54

1.42

3.4

2.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

3.06

1.38

1.0

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

596

1.84

1.36

25.6

12.5

32.0

24.9

mg/l

1.16

453

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2.23

1.34

1.6

1.7

28.2

29.6

u/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

203

1.65

1.29

2.6

2.9

—

(3002582) Erythrocytes [#/volume] in Urine

179

1.65

1.23

2.7

110.3

389.7

e6/l

0.34

135

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

590

0.63

1.22

5.2

6.3

39.6

41.5

mmol/mol

0.96

543

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2.59

1.17

1.6

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2.45

1.15

1.4

1.8

10.8

9.1

g/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

614

0.64

1.14

4.7

5.4

2.7

2.6

mmol/l

0.42

558

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.87

1.10

6.0

8.9

—

(3019060) Gas panel - Arterial blood

2.02

1.06

8.1

3.6

—

(3030467) Casts [#/volume] in Urine by Automated count

168

1.60

1.05

2.8

2.6

1.3

0.3

e6/l

0.52

121

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

423

1.51

1.04

5.1

3.7

14.0

15.1

pmol/l

1.69

373

(40761535) Cells panel - Urine sediment

1.97

1.01

2.8

3.2

—

(36304419) Bacteria [Presence] in Urine

161

1.59

1.01

2.7

2.5

—

(3019225) pH of Specimen

1.93

0.97

2.9

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

223

0.60

0.96

4.3

4.2

10.8

12.2

mg/mmol

—

138

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.97

0.96

2.7

2.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.97

0.96

4.7

3.5

1.3

1.2

mmol/l

—

(3012544) pH of Venous blood

1.86

0.95

2.0

3.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2.23

0.93

1.2

1.1

—

(3018095) Leukocytes [#/volume] in Urine

200

1.51

0.92

2.9

3.2

240.3

67.7

e6/l

0.48

144

(3026008) Bacteria identified in Urine by Culture

140

1.56

0.87

3.9

2.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.80

0.87

1.0

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.86

0.87

1.0

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.86

0.87

1.0

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2.00

0.86

1.2

1.4

—

(3000991) Gas panel - Venous blood

1.73

0.81

9.0

8.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.82

0.78

2.7

5.0

25.0

25.2

mmol/l

—

(3049717) Cytology report of Urine Cyto stain

2.24

0.77

1.8

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.24

0.77

1.6

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.92

0.76

1.7

1.4

—

(40761511) CBC panel - Blood by Automated count

628

1.52

0.75

23.2

12.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

594

0.71

0.72

3.9

4.8

1.5

1.4

mmol/l

0.68

540

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.98

0.72

1.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.73

0.70

2.3

2.4

120.7

126.3

g/l

—

(3044889) 12 lead EKG panel

453

1.38

0.69

4.9

4.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.90

0.69

1.2

1.3

—

(36660697) Celiac disease serology panel - Serum

1.68

0.68

1.0

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

217

0.68

0.66

2.6

3.3

6.6

7.6

mmol/l

0.71

182

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

599

0.73

0.64

4.3

4.8

4.7

4.5

mmol/l

0.58

547

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

299

1.35

0.64

2.4

2.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.71

0.62

10.6

8.2

25.6

mmol/l

—

(3021589) Normoblasts [#/volume] in Blood

243

1.36

0.62

10.4

8.6

0.0

e9/l

0.00

200

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.61

0.0

1.4

—

(40768797) Stomach Pathology biopsy report

1.56

0.61

1.3

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.62

0.55

10.5

8.1

0.6

0.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.62

0.55

10.5

8.2

95.1

92.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.58

0.54

10.5

8.1

1.6

1.7

—

(3002032) Base excess in Venous blood by calculation

1.45

0.53

2.2

3.8

1.8

2.3

mmol/l

—

(3012516) Albumin [Mass/volume] in Urine

209

0.71

0.53

2.8

3.5

38.1

373.7

mg/l

—

139

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.47

0.52

2.3

2.9

0.9

0.7

e6/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

102

1.45

0.51

2.3

2.5

1.2

0.9

e6/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

643

1.39

0.50

30.7

15.3

83.2

85.8

umol/l

0.15

643

(3009542) Hematocrit [Volume Fraction] of Blood

529

1.30

0.48

24.0

13.0

39.0

40.7

0.61

365

(1761868) Lipid panel - Serum or Plasma

193

0.73

0.45

2.5

3.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.49

0.44

1.2

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

392

1.25

0.42

5.5

3.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.41

0.0

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

127

1.32

0.37

3.1

3.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

281

0.80

0.36

4.5

3.6

25.5

24.4

0.13

121

(3022621) pH of Urine by Test strip

1.39

0.35

2.8

2.0

—

(3017732) Neutrophils [#/volume] in Blood

1.33

0.34

9.5

2.8

4.4

3.3

e9/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

273

1.21

0.31

3.7

3.9

23.8

44.0

ng/l

1.51

198

(3002385) Erythrocyte distribution width [Ratio]

482

1.20

0.30

28.4

14.2

14.0

13.6

1.81

470

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.27

0.30

5.4

2.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1.27

0.30

3.7

3.5

473.0

170.0

ng/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

242

0.82

0.27

2.2

2.0

100.4

91.2

pmol/l

0.46

120

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

1.6

—

104.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

1.6

—

4.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

542

1.16

0.20

6.6

4.4

3.4

2.0

mu/l

2.28

481

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

577

0.87

0.20

3.4

4.3

1.3

mmol/l

0.08

523

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

200

0.87

0.14

3.0

2.5

0.8

ug/l

0.01

125

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

590

0.90

0.13

4.4

4.7

5.8

6.2

mmol/l

1.79

526

(3013512) EKG study

192

1.12

0.12

3.5

3.8

—

(40761536) Microorganisms panel - Urine sediment

1.14

0.10

4.8

3.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

644

1.11

0.10

15.0

8.9

23.2

25.9

u/l

0.81

612

(3041096) Erythrocytes [Presence] in Urine by Automated

154

0.89

0.09

4.8

2.8

—

(3022145) Colonoscopy Study observation

1.04

0.08

1.3

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

270

0.95

0.04

7.4

4.4

0.0

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

270

0.95

0.04

4.8

3.4

0.0

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

278

0.96

0.02

4.3

3.4

0.0

estimate

—

(3015736) pH of Urine

204

1.04

0.00

4.4

3.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

566

0.97

0.00

24.9

11.5

81.5

76.4

ml/min/173m2

0.83

462

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.8

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(4062490)

0.00

0.0

1.3

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3000492) Spirometry study

1.00

0.00

1.2

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.8

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.0

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

4.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.0

—

(4306422)

0.00

0.0

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

468.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

220

1.00

0.00

6.5

3.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.0

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.8

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_LIP_ORAL_PHARYNX_NAS_EXALLC – Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers) (C3_LIP_ORAL_PHARYNX_NAS_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints